The viable tumor samples are good examples of whole processed tissues which are widely used in basic oncology disease research as well as drug development.
Studies on immune disorders are done only with viable tumor samples as these have unique characteristics such as these proliferate indefinitely when cultured (HeLa cell lines), no contact inhibition, abnormal karyotype, and simple media requirement.
Viable tumor samples have limitless applications in research especially for autoimmune disorder and oncology research to detect cell markers, efficacy testing of drugs, and in providing insights into the physiological mechanisms of diseases.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=20852Major market players in the global viable tumor samples market provide quality controlled viable tumor cells with correct analysis, ensure proper fixation, and confirm the tissue and tumor size.
However, requirement of skilled professionals, high cost of development and maintenance of viable tumor samples, and stringent regulatory policies are expected to restrain the global viable tumor samples market.Request TOC of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=T_id=20852 The global viable tumor samples market has been segmented based on cancer type, method of storage, application, and end-user.
Flash freezing treatments such as cryopreservation of viable tumor samples can store them till 10 years, hence are used more frequently.
New methods such as Formalin-Fixed, Paraffin Embedded (FPFE) have certain advantages such as rapid and precise extraction of DNA.